Renin-angiotensin system (RAS) inhibition supposedly increases the expression of angiotensin converting enzyme 2, serving as a binding site for SARS-CoV-2. Concerns arose regarding therapy with RAS inhibition during the COVID-19 pandemic. However, the pharmacological restraining the classical RAS axis might be beneficial due to the reduction of deleterious effects of angiotensin II and enhancement of the anti-inflammatory angiotensin 1-7 pathway. Unless large controlled studies are performed, RAS inhibition remains the cornerstone therapy in populations with cardiovascular disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4149/gpb_2020019 | DOI Listing |
Publication Analysis
Top Keywords
ras inhibition
12
renin-angiotensin system
8
system sars-cov-2
4
sars-cov-2 interaction
4
interaction underlying
4
underlying mechanisms
4
mechanisms potential
4
potential clinical
4
clinical implications
4
implications renin-angiotensin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!